EntheoTech Bioscience opens flagship ketamine clinic in Kelowna
The British Columbia-based psychedelics company EntheoTech Bioscience has opened a 3,000-square-foot ketamine therapy clinic in Kelowna after
The British Columbia-based psychedelics company EntheoTech Bioscience has opened a 3,000-square-foot ketamine therapy clinic in Kelowna after
The global market for psychedelic drugs will be worth US$8.3 billion in four years, according to the French market researcher Report Linker. Report
A southern California-based therapy clinic that utilizes ketamine to address root causes of mental and chronic physical health issues has opened its
An astronaut en route to Mars develops severe abdominal pain, nausea, and vomiting. A fellow crew member examines him and finds significant
Expanding Reach in Rapidly Growing Ketamine Therapy Market LOS ANGELES, March 22, 2023 (GLOBE NEWSWIRE) — Irwin Naturals Inc. (CSE: IWIN)
Background: The immediate post intubation period in the ED is a critical time for continued patient stabilization. While physical adjuncts like
Written by: Brian Lin, MD Edited by: Anand Swaminathan, MD Posted: August 3, 2016 Updated by: Victor Lei, MD Edited by: Gregg Chesney,
Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) has signed an agreement with an anonymous entity in Portugal to help establish a
Episode Summary Welcome back to the show! On this episode of The Erica Diamond Podcast, I get up close and person with Dr. Steven Radowitz,
Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF) has extended its psychedelic-assisted clinical research to Phoenix and expanded its facility
Many startup companies developing psychedelic therapies work with classic mind-altering substances such as psilocybin, mescaline and LSD. Jonathan
Calgary-based ATMA Journey Centers has launched one of the first psychedelic training programs for physicians and health professionals in
Strategic transaction assembles an experienced management and scientific team world-renowned in mental health treatment, research and
Welcome to the last 2022 edition of SharpBrains e‑newsletter, featuring a few selected brain health news and fun teasers to challenge your brain
Awakn Life Sciences (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) has received a $2.5 million grant from health authorities in the United Kingdom to